| MOPEE23 | Smartphone- enabled video directly observed therapy to improve viral suppression among unsuppressed children and adolescents in Kenya | Poster exhibition | Implementation science and scale up of treatment |
| MOPEE22 | Community Retail Pharmacy Drug Distribution Points (CRPDDPs) to provide a convenient, cost-saving, client-preferred model for pick-up of antiretrovirals in Uganda | Poster exhibition | Implementation science and scale up of treatment |
| MOPEE21 | Lessons Learned from the introduction of advanced HIV disease package of care in Nigeria | Poster exhibition | Implementation science and scale up of treatment |
| MOPEE20 | A Quality Improvement Collaborative improves viral load testing coverage in Western Province, Zambia | Poster exhibition | Implementation science and scale up of treatment |
| MOPEE19 | Fast-tracking treatment optimization to address treatment continuity among PLHIV through comprehensive approach and use of digital and telehealth platforms during the COVID -19 pandemic in Andhra Pradesh, India | Poster exhibition | Implementation science and scale up of treatment |
| MOPEE18 | Evidence of peer-led demedicalized delivery of same-day PrEP in various community centers in the Philippines | Poster exhibition | Implementation science and scale up of prevention |
| MOPEE17 | High rate of missed HIV testing among oral PrEP users from 2018-2020 in the United States: a national assessment on compliance with HIV testing recommendations of the CDC PrEP Guidelines | Poster exhibition | Implementation science and scale up of prevention |
| MOPEE16 | Preparing for next-generation PrEP: awareness and willingness to use long acting injectable cabotegravir (CAB-LA) among men who have sex with men and trans women across Asia and Australia | Poster exhibition | Implementation science and scale up of prevention |
| MOPEE15 | Machine learning models to predict lost to follow-up of people receiving antiretroviral therapy in Brazil, 2014-2022 | Poster exhibition | Implementation science and scale up of treatment |
| MOPEE14 | Who chooses event-driven PrEP (PrEP 2-1-1) in a US national cohort? Exploring the role of demographics, wealth, access to health care, sexual behavior and practices on PrEP choice | Poster exhibition | Implementation science and scale up of prevention |